Cargando…

Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles

BACKGROUND: OnabotulinumtoxinA has demonstrated the ability to eliminate mild glabellar lines at rest; however, less is known regarding the effect of repeat treatment on more severe lines at rest. OBJECTIVE: To assess the effect of repeated onabotulinumtoxinA treatment for reduction of glabellar lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Carruthers, Alastair, Carruthers, Jean, Fagien, Steven, Lei, Xiaofang, Kolodziejczyk, Julia, Brin, Mitchell F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414762/
https://www.ncbi.nlm.nih.gov/pubmed/27427996
http://dx.doi.org/10.1097/DSS.0000000000000704
_version_ 1783233415744585728
author Carruthers, Alastair
Carruthers, Jean
Fagien, Steven
Lei, Xiaofang
Kolodziejczyk, Julia
Brin, Mitchell F.
author_facet Carruthers, Alastair
Carruthers, Jean
Fagien, Steven
Lei, Xiaofang
Kolodziejczyk, Julia
Brin, Mitchell F.
author_sort Carruthers, Alastair
collection PubMed
description BACKGROUND: OnabotulinumtoxinA has demonstrated the ability to eliminate mild glabellar lines at rest; however, less is known regarding the effect of repeat treatment on more severe lines at rest. OBJECTIVE: To assess the effect of repeated onabotulinumtoxinA treatment for reduction of glabellar lines at rest. METHODS: Subjects 18 to 75 years old with at least mild glabellar lines at rest, as assessed by the validated Facial Wrinkle Scale (FWS) with photonumeric guide (score ≥ 1), received 3 treatments of 20 U onabotulinumtoxinA 4 months apart (N = 225). “Response” was defined as elimination of glabellar lines at rest (FWS score = 0) at any time point (Days 7, 30, 60, 90, and 120). Effect of treatment cycle on response was analyzed using repeated measures logistic regressions (p < .05). RESULTS: Most subjects were female (85%) and white (88%) (age range: 35–54 years). The likelihood of significant response was as follows: for all subjects combined (odds ratio [OR]: 1.31), for subjects with mild resting lines at baseline (OR: 1.49), and for older women (≥55 years) with mild resting lines at baseline (OR: 2.22). Of all subjects, 76% responded after 1 treatment, and 45% responded in all 3 cycles. CONCLUSION: Subjects repeatedly treated with onabotulinumtoxinA showed progressive improvement in glabellar lines at rest.
format Online
Article
Text
id pubmed-5414762
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-54147622017-05-10 Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles Carruthers, Alastair Carruthers, Jean Fagien, Steven Lei, Xiaofang Kolodziejczyk, Julia Brin, Mitchell F. Dermatol Surg Original Article BACKGROUND: OnabotulinumtoxinA has demonstrated the ability to eliminate mild glabellar lines at rest; however, less is known regarding the effect of repeat treatment on more severe lines at rest. OBJECTIVE: To assess the effect of repeated onabotulinumtoxinA treatment for reduction of glabellar lines at rest. METHODS: Subjects 18 to 75 years old with at least mild glabellar lines at rest, as assessed by the validated Facial Wrinkle Scale (FWS) with photonumeric guide (score ≥ 1), received 3 treatments of 20 U onabotulinumtoxinA 4 months apart (N = 225). “Response” was defined as elimination of glabellar lines at rest (FWS score = 0) at any time point (Days 7, 30, 60, 90, and 120). Effect of treatment cycle on response was analyzed using repeated measures logistic regressions (p < .05). RESULTS: Most subjects were female (85%) and white (88%) (age range: 35–54 years). The likelihood of significant response was as follows: for all subjects combined (odds ratio [OR]: 1.31), for subjects with mild resting lines at baseline (OR: 1.49), and for older women (≥55 years) with mild resting lines at baseline (OR: 2.22). Of all subjects, 76% responded after 1 treatment, and 45% responded in all 3 cycles. CONCLUSION: Subjects repeatedly treated with onabotulinumtoxinA showed progressive improvement in glabellar lines at rest. Lippincott Williams & Wilkins 2016-09 2016-06-14 /pmc/articles/PMC5414762/ /pubmed/27427996 http://dx.doi.org/10.1097/DSS.0000000000000704 Text en © 2016 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Original Article
Carruthers, Alastair
Carruthers, Jean
Fagien, Steven
Lei, Xiaofang
Kolodziejczyk, Julia
Brin, Mitchell F.
Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
title Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
title_full Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
title_fullStr Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
title_full_unstemmed Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
title_short Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
title_sort repeated onabotulinumtoxina treatment of glabellar lines at rest over three treatment cycles
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414762/
https://www.ncbi.nlm.nih.gov/pubmed/27427996
http://dx.doi.org/10.1097/DSS.0000000000000704
work_keys_str_mv AT carruthersalastair repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles
AT carruthersjean repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles
AT fagiensteven repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles
AT leixiaofang repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles
AT kolodziejczykjulia repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles
AT brinmitchellf repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles